Literature DB >> 28904076

Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus.

Anna Grodzinsky1, Mikhail Kosiborod2, Fengming Tang2, Philip G Jones2, Darren K McGuire2, John A Spertus2, John F Beltrame2, Jae-Sik Jang2, Abhinav Goyal2, Neel M Butala2, Robert W Yeh2, Suzanne V Arnold2.   

Abstract

BACKGROUND: Previous studies suggest that among patients with stable coronary artery disease, patients with diabetes mellitus (DM) have less angina and more silent ischemia when compared with those without DM. However, the burden of angina in diabetic versus nondiabetic patients after elective percutaneous coronary intervention (PCI) has not been recently examined. METHODS AND
RESULTS: In a 10-site US PCI registry, we assessed angina before and at 1, 6, and 12 months after elective PCI with the Seattle Angina Questionnaire angina frequency score (range, 0-100, higher=better). We also examined the rates of antianginal medication prescriptions at discharge. A multivariable, repeated-measures Poisson model was used to examine the independent association of DM with angina over the year after treatment. Among 1080 elective PCI patients (mean age, 65 years; 74.7% men), 34.0% had DM. At baseline and at each follow-up, patients with DM had similar angina prevalence and severity as those without DM. Patients with DM were more commonly prescribed calcium channel blockers and long-acting nitrates at discharge (DM versus not: 27.9% versus 20.9% [P=0.01] and 32.8% versus 25.5% [P=0.01], respectively), whereas β-blockers and ranolazine were prescribed at similar rates. In the multivariable, repeated-measures model, the risk of angina was similar over the year after PCI in patients with versus without DM (relative risk, 1.04; range, 0.80-1.36).
CONCLUSIONS: Patients with stable coronary artery disease and DM exhibit a burden of angina that is at least as high as those without DM despite more antianginal prescriptions at discharge. These findings contradict the conventional teachings that patients with DM experience less angina because of silent ischemia.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  coronary artery disease; diabetes mellitus; myocardial ischemia; percutaneous coronary intervention; risk

Mesh:

Year:  2017        PMID: 28904076      PMCID: PMC5611809          DOI: 10.1161/CIRCOUTCOMES.117.003553

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  27 in total

1.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

2.  Improving the process of informed consent for percutaneous coronary intervention: patient outcomes from the Patient Risk Information Services Manager (ePRISM) study.

Authors:  John A Spertus; Richard Bach; Charles Bethea; Adnan Chhatriwalla; Jeptha P Curtis; Elizabeth Gialde; Mayra Guerrero; Kensey Gosch; Philip G Jones; Aaron Kugelmass; Bradley M Leonard; Edward J McNulty; Marc Shelton; Henry H Ting; Carole Decker
Journal:  Am Heart J       Date:  2014-11-15       Impact factor: 4.749

3.  Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina.

Authors:  S J Pocock; R A Henderson; T Clayton; G H Lyman; D A Chamberlain
Journal:  J Am Coll Cardiol       Date:  2000-03-15       Impact factor: 24.094

4.  Silent myocardial ischaemia in patients with type II diabetes mellitus and its relation with autonomic dysfunction.

Authors:  R Sukhija; D Dhanwal; D S Gambhir; R Dewan
Journal:  Indian Heart J       Date:  2000 Sep-Oct

5.  Factors associated with 30-day readmission rates after percutaneous coronary intervention.

Authors:  Farhan J Khawaja; Nilay D Shah; Ryan J Lennon; Joshua P Slusser; Aziz A Alkatib; Charanjit S Rihal; Bernard J Gersh; Victor M Montori; David R Holmes; Malcolm R Bell; Jeptha P Curtis; Harlan M Krumholz; Henry H Ting
Journal:  Arch Intern Med       Date:  2011-11-28

6.  Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes.

Authors:  B Marchant; V Umachandran; R Stevenson; P G Kopelman; A D Timmis
Journal:  J Am Coll Cardiol       Date:  1993-11-01       Impact factor: 24.094

7.  Association between diabetes mellitus and angina after acute myocardial infarction: analysis of the TRIUMPH prospective cohort study.

Authors:  Suzanne V Arnold; John A Spertus; Kasia J Lipska; Fengming Tang; Abhinav Goyal; Darren K McGuire; Sharon Cresci; Thomas M Maddox; Mikhail Kosiborod
Journal:  Eur J Prev Cardiol       Date:  2014-04-16       Impact factor: 7.804

8.  Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease.

Authors:  J A Spertus; J A Winder; T A Dewhurst; R A Deyo; J Prodzinski; M McDonell; S D Fihn
Journal:  J Am Coll Cardiol       Date:  1995-02       Impact factor: 24.094

9.  Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial.

Authors:  Suzanne V Arnold; David A Morrow; Yang Lei; David J Cohen; Elizabeth M Mahoney; Eugene Braunwald; Paul S Chan
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-06-02

10.  The impact of diabetes on one-year health status outcomes following acute coronary syndromes.

Authors:  Pamela N Peterson; John A Spertus; David J Magid; Fredrick A Masoudi; Kimberly Reid; Richard F Hamman; John S Rumsfeld
Journal:  BMC Cardiovasc Disord       Date:  2006-10-24       Impact factor: 2.298

View more
  3 in total

Review 1.  Management of Angina Post Percutaneous Coronary Intervention.

Authors:  Jose B Cruz Rodriguez; Subrata Kar
Journal:  Curr Cardiol Rep       Date:  2020-01-21       Impact factor: 2.931

2.  Validation of algorithms to identify elective percutaneous coronary interventions in administrative databases.

Authors:  Catherine G Derington; Lauren J Heath; David P Kao; Thomas Delate
Journal:  PLoS One       Date:  2020-04-07       Impact factor: 3.240

3.  Myocardial injury in diabetic patients with multivessel coronary artery disease after revascularization interventions.

Authors:  Paulo Cury Rezende; Whady Hueb; Rosa Maria Rahmi; Thiago Luis Scudeler; Diogo Freitas Cardoso de Azevedo; Cibele Larrosa Garzillo; Carlos Alexandre Wainrober Segre; Jose Antonio Franchini Ramires; Roberto Kalil Filho
Journal:  Diabetol Metab Syndr       Date:  2017-11-21       Impact factor: 3.320

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.